title: Midterm experience with the endovascular treatment of isolated iliac aneurysms.
abstract: OBJECTIVE
  This report describes our 5-year experience with the endovascular repair of isolated iliac aneurysms and pseudoaneurysms.
  
  
  METHODS
  Between June 1993 and July 1998, 40 isolated iliac aneurysms and pseudoaneurysms were treated with endovascular grafts in 39 patients. Thirty-seven aneurysms were treated with endovascular grafts composed of polytetrafluoroethylene grafts and balloon expandable stents, and the other three underwent repair with a polycarbonate urethane endoluminal graft.
  
  
  RESULTS
  All the patients underwent initially successful endovascular treatment of isolated iliac aneurysms and pseudoaneurysms and were followed from 1 to 51 months (mean, 18 months). The 4-year primary patency rate was 94.5% +/- 10%. The perioperative complications included one episode of distal embolization, an episode of colonic ischemia, five episodes of kinking or compression of the endovascular graft, and one early postoperative graft thrombosis. There was only one perioperative death in a patient whose aneurysm ruptured in the operating room just before endovascular repair. The median postoperative length of hospital stay was 3.0 +/- 1.3 days in this group of patients at moderate and high risk. The long-term complications included one graft thrombosis and two endoleaks. One small endoleak was followed until the patient died of unrelated causes, and the other one led to aneurysm rupture in the only patient temporarily lost to follow-up examination. This patient successfully underwent treatment in the standard open surgical fashion. To date, all the other aneurysms have remained stable or have decreased in size during the follow-up examinations with duplex or contrast-enhanced computed tomographic scans.
  
  
  CONCLUSIONS
  Endovascular repair of iliac aneurysms and pseudoaneurysms is a safe and effective technique with good midterm results in patients at standard and high risk. These grafts are particularly beneficial for patients with medical, surgical, or anatomic contraindications for open surgical repair.
authors.affiliation: Division of Vascular Surgery, Montefiore Medical Center, New York, NY, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Sanchez
authors.forename: A V
authors.initials: AV
authors.lastname: Patel
authors.forename: T
authors.initials: T
authors.lastname: Ohki
authors.forename: W D
authors.initials: WD
authors.lastname: Suggs
authors.forename: R A
authors.initials: RA
authors.lastname: Wain
authors.forename: J
authors.initials: J
authors.lastname: Valladares
authors.forename: J
authors.initials: J
authors.lastname: Cynamon
authors.forename: J
authors.initials: J
authors.lastname: Rigg
authors.forename: F J
authors.initials: FJ
authors.lastname: Veith
mesh_terms: D017541:Aneurysm, False / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods; D005260:Female; D006801:Humans; D017543:Iliac Aneurysm / Q000601:surgery*; D008297:Male; D011138:Polytetrafluoroethylene; D015607:Stents; D016896:Treatment Outcome
chemical_list: D011138:Polytetrafluoroethylene